You are here : Moneycontrol » Markets » » Competition - Solvay Pharma India

Solvay Pharma India

BSE: 532447|ISIN: INE593D01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
Solvay Pharma India is not traded in the last 30 days
Solvay Pharma India is not listed on NSE

Competition

Name Last Price Market Cap.
(Rs. cr.)
Sales
Turnover
Net Profit Total Assets
ABB Power Produ 1,839.05 7,794.20 3,420.44 99.80 932.52
Abesc 128.30 309.84 -- -- -
PP1 66.25 130.50 -- -- -
Ndr Auto Compon 219.15 130.31 114.13 6.94 139.62
Wonder Fibromat 68.25 57.16 297.27 4.44 55.48
Gateway Dist-RE 17.30 27.84 -- -- -
Vaxtex 46.05 27.74 27.78 0.09 21.28
Arvind Fas-RE 18.50 27.28 -- -- -
Archidply Decor 34.25 19.06 40.27 -1.13 71.51
Avro India 43.95 14.30 44.07 1.14 15.75
Bodhi Tree Mult 72.00 9.00 26.71 3.66 -
SBI ETF PVT BAN 184.00 0.00 -- -- -
Sov Gold 2028-V 4,730.00 0.00 -- -- -
HDFC Banking ET 347.96 0.00 -- -- -
SGBJULY28-Sr.IV 4,773.74 0.00 -- -- -
GB 2.50% Dec'27 4,744.23 0.00 -- -- -
SGB 2.5% JUN 28 4,723.10 0.00 -- -- -
Reliance Indust 222.00 0.00 -- -- -
GB 2.50% 2027 S 4,750.00 0.00 -- -- -
SGB 2.50% SrII 4,733.61 0.00 -- -- -
S & S Power 8.50 0.00 -- -- -
SGB 2.50% 2027 4,800.00 0.00 -- -- -
SGB 2.50% Apr28 4,770.00 0.00 -- -- -
NI ETF Nifty IT 28.70 0.00 -- -- -
SGB 2.50% Sr-II 4,761.01 0.00 -- -- -
SGB 2.50% SrIX 4,755.01 0.00 -- -- -
Tata Steel PP 233.30 0.00 -- -- -
Sov Gold 2018-1 4,795.00 0.00 -- -- -
SGB 2.50% Sr-X 4,752.01 0.00 -- -- -
IP IT ETF 286.18 0.00 -- -- -
SGB Series IX 4,020.00 0.00 -- -- -
Compare Solvay Pharma with another company    

Comparison with Competitors

Quick Links for Solvay Pharma India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.